Atrion Corp (ATRI)
472.50
+0.10
(+0.02%)
USD |
NASDAQ |
May 21, 09:43
Atrion Enterprise Value: 821.53M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 821.53M |
| May 17, 2024 | 808.94M |
| May 16, 2024 | 792.38M |
| May 15, 2024 | 863.05M |
| May 14, 2024 | 827.57M |
| May 13, 2024 | 763.98M |
| May 10, 2024 | 773.92M |
| May 09, 2024 | 743.03M |
| May 08, 2024 | 712.02M |
| May 07, 2024 | 724.38M |
| May 06, 2024 | 755.70M |
| May 03, 2024 | 720.42M |
| May 02, 2024 | 720.42M |
| May 01, 2024 | 741.41M |
| April 30, 2024 | 735.10M |
| April 29, 2024 | 729.30M |
| April 26, 2024 | 685.32M |
| April 25, 2024 | 692.29M |
| April 24, 2024 | 736.68M |
| April 23, 2024 | 703.42M |
| April 22, 2024 | 693.81M |
| April 19, 2024 | 698.24M |
| April 18, 2024 | 668.94M |
| April 17, 2024 | 691.92M |
| April 16, 2024 | 710.17M |
| Date | Value |
|---|---|
| April 15, 2024 | 691.78M |
| April 12, 2024 | 692.96M |
| April 11, 2024 | 699.56M |
| April 10, 2024 | 742.65M |
| April 09, 2024 | 767.57M |
| April 08, 2024 | 723.62M |
| April 05, 2024 | 722.44M |
| April 04, 2024 | 728.65M |
| April 03, 2024 | 703.45M |
| April 02, 2024 | 660.82M |
| April 01, 2024 | 709.59M |
| March 31, 2024 | 805.95M |
| March 28, 2024 | 809.50M |
| March 27, 2024 | 782.13M |
| March 26, 2024 | 762.92M |
| March 25, 2024 | 762.78M |
| March 22, 2024 | 743.79M |
| March 21, 2024 | 773.12M |
| March 20, 2024 | 761.19M |
| March 19, 2024 | 747.99M |
| March 18, 2024 | 754.33M |
| March 15, 2024 | 761.19M |
| March 14, 2024 | 729.43M |
| March 13, 2024 | 742.31M |
| March 12, 2024 | 757.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
509.10M
Minimum
Nov 15 2023
1.625B
Maximum
May 21 2019
1.082B
Average
1.111B
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 835.95M |
| Retractable Technologies Inc | -17.77M |
| Xtant Medical Holdings Inc | 116.96M |
| Asensus Surgical Inc | 60.09M |
| Catheter Precision Inc | 2.901M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.792M |
| Revenue (Quarterly) | 47.33M |
| Total Expenses (Quarterly) | 44.19M |
| EPS Diluted (Quarterly) | 1.59 |
| Gross Profit Margin (Quarterly) | 26.09% |
| Profit Margin (Quarterly) | 5.90% |
| Earnings Yield | 2.25% |
| Operating Earnings Yield | 2.55% |
| Normalized Earnings Yield | 2.276 |